Management of Acute Severe Colitis in Children With Ulcerative Colitis in the Biologics Era

被引:17
作者
Romano, Claudio [1 ]
Syed, Sana [2 ]
Valenti, Simona [1 ]
Kugathasan, Subra [2 ]
机构
[1] Univ Messina, Dept Pediat, Inflammatory Bowel Dis Unit, Viale Consolare Valeria, I-98122 Messina, Italy
[2] Emory Univ, Sch Med, Dept Pediat, Div Pediat Gastroenterol Hepatol & Nutr, Atlanta, GA USA
关键词
INFLAMMATORY-BOWEL-DISEASE; EVIDENCE-BASED CONSENSUS; ADVERSE EVENTS; CYCLOSPORINE; ARTICLE; CYTOMEGALOVIRUS; INFLIXIMAB; OUTCOMES; SURGERY; ADULTS;
D O I
10.1542/peds.2015-1184
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
BACKGROUND AND OBJECTIVE: Approximately one-third of children with ulcerative colitis will experience at least 1 attack of acute severe colitis (ASC) before 15 years of age. Severe disease can be defined in children when Pediatric Ulcerative Colitis Activity Index is >65 and/or >= 6 bloody stools per day, and/or 1 of the following: tachycardia, fever, anemia, and elevated erythrocyte sedimentation rate with or without systemic toxicity. Our aim was to provide practical suggestions on the management of ASC in children. The goal of medical therapy is to avoid colectomy while preventing complications of disease, side effects of medications, and mortality. METHODS: A systematic search was carried out through Medline via PubMed to identify all articles published in English to date, based on the following keywords "ulcerative colitis, " "pediatric ulcerative colitis, " "biological therapy, " and "acute severe colitis." Multidisciplinary clinical evaluation is recommended to identify early nonresponders to conventional treatment with intravenous corticosteroids, and to start, if indicated, second-line therapy or "rescue therapy, "such as calcineurin inhibitors (cyclosporine, tacrolimus) and anti-tumor necrosis factor molecules (infliximab). RESULTS: Pediatric Ulcerative Colitis Activity Index is a valid predictive tool that can guide clinicians in evaluating response to therapy. Surgery should be considered in the case of complications or rapid clinical deterioration during medical treatment. CONCLUSIONS: Several pitfalls may be present in the management of ASC, and a correct clinical and therapeutic approach is recommended to reduce surgical risk.
引用
收藏
页数:9
相关论文
共 51 条
[1]   Efficacy and efficiency of oral microemulsion cyclosporin versus intravenous and soft gelatin capsule cyclosporin in the treatment of severe steroid-refractory ulcerative colitis: An open-label retrospective trial [J].
Actis, GC ;
Aimo, G ;
Priolo, G ;
Moscato, D ;
Rizzetto, M ;
Pagni, R .
INFLAMMATORY BOWEL DISEASES, 1998, 4 (04) :276-279
[2]   Inflammatory Bowel Disease in the Elderly Is Associated With Worse Outcomes: A National Study of Hospitalizations [J].
Ananthakrishnan, Ashwin N. ;
McGinley, Emily L. ;
Binion, David G. .
INFLAMMATORY BOWEL DISEASES, 2009, 15 (02) :182-189
[3]  
Arnott ID, 2010, GASTROENTEROLOGY, V138, pS106
[4]   Severe attack of ulcerative colitis in children: retrospective clinical survey [J].
Barabino, A ;
Tegaldo, L ;
Castellano, E ;
Gandullia, P ;
Torrente, F ;
Marino, C ;
Mattioli, G ;
Jasonni, V .
DIGESTIVE AND LIVER DISEASE, 2002, 34 (01) :44-49
[5]   Current approaches to the management of new-onset ulcerative colitis [J].
Beery, Renee Marchioni ;
Kane, Sunanda .
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2014, 7 :111-132
[6]   A Review of Mortality and Surgery in Ulcerative Colitis: Milestones of the Seriousness of the Disease [J].
Bernstein, Charles N. ;
Ng, Siew C. ;
Lakatos, Peter L. ;
Moum, Bjorn ;
Loftus, Edward V., Jr. .
INFLAMMATORY BOWEL DISEASES, 2013, 19 (09) :2001-2010
[7]   Pediatric ulcerative colitis: current treatment approaches including role of infliximab [J].
Bradley, Gia M. ;
Oliva-Hemker, Maria .
BIOLOGICS-TARGETS & THERAPY, 2012, 6 :125-134
[8]   Historical evolution of the management of severe ulcerative colitis [J].
Caprilli, Renzo ;
Clemente, Valeria ;
Frieri, Giuseppe .
JOURNAL OF CROHNS & COLITIS, 2008, 2 (03) :263-268
[9]   Role of cyclosporin in preventing or delaying colectomy in children with severe ulcerative colitis [J].
Castro, M. ;
Papadatou, B. ;
Ceriati, E. ;
Knafelz, D. ;
De Angelis, P. ;
Ferretti, F. ;
Gambarara, M. ;
Diamanti, A. ;
De Peppo, F. ;
Rivosecchi, M. .
LANGENBECKS ARCHIVES OF SURGERY, 2007, 392 (02) :161-164
[10]   Outcome measurement in clinical trials for Ulcerative Colitis: towards standardisation [J].
Cooney, Rachel M. ;
Warren, Bryan F. ;
Altman, Douglas G. ;
Abreu, Maria T. ;
Travis, Simon P. L. .
TRIALS, 2007, 8 (1)